Islet amyloid polypeptide toxicity and membrane interactions

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 48, 2013, Pages 19279-19284

  Cao, Ping ^a   Abedini, Andisheh ^b   Wang, Hui ^a   Tu, Ling Hsien ^a   Zhang, Xiaoxue ^a   Schmidt, Ann Marie ^b   Raleigh, Daniel P ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN INTERACTION; RAT; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

AMINO ACID SEQUENCE; AMYLOID; ANIMALS; BIOPHYSICS; DIABETES MELLITUS, TYPE 2; HUMANS; ISLET AMYLOID POLYPEPTIDE; MEMBRANES, ARTIFICIAL; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR SEQUENCE DATA; OXAZINES; RATS; SPECIES SPECIFICITY; THIAZOLES; XANTHENES;

EID: 84888353824     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1305517110     Document Type: Article

References (47)

1. Selkoe DJ (2004) Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 6(11): 1054-1061.
2. Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333-366.
3. Clark A, et al. (1988) Islet amyloid, increased alpha-cells, reduced beta-cells and exocrine fibrosis: Quantitative changes in the pancreas in type-2 diabetes. Diabetes Res Clin Ex 9(4): 151-159.
4. Lorenzo A, Razzaboni B, Weir GC, Yankner BA (1994) Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368(6473): 756-760.
5. Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJ (2006) The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells. FEBS J 273(15): 3614-3624.
6. Cao P, et al. (2013) Islet amyloid: From fundamental biophysics to mechanisms of cytotoxicity. FEBS Lett 587(8): 1106-1118.
7. Ashcroft FM, Rorsman P (2012) Diabetes mellitus and the β cell: The last ten years. Cell 148(6): 1160-1171.
8. Potter KJ, et al. (2010) Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci USA 107(9): 4305-4310.
9. Westermark GT, Westermark P, Berne C, Korsgren O, Transpla NNCI; Nordic Network for Clinical Islet Transplantation (2008) Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med 359(9): 977-979.
10. Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32(4): 240-244.
11. Kahn SE, et al. (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39(5): 634-638.
12. Lutz TA (2012) Control of energy homeostasis by amylin. Cell Mol Life Sci 69(12): 1947-1965.
13. Westermark P, Andersson A, Westermark GT (2011) Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev 91(3): 795-826.
14. Knight JD, Hebda JA, Miranker AD (2006) Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. Biochemistry 45(31): 9496-9508.
15. Hebda JA, Miranker AD (2009) The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: Insights from type II diabetes. Annu Rev Biophys 38: 125-152.
16. Jayasinghe SA, Langen R (2007) Membrane interaction of islet amyloid polypeptide. Biochim Biophys Acta 1768(8): 2002-2009.
17. Engel MFM (2009) Membrane permeabilization by Islet Amyloid Polypeptide. Chem Phys Lipids 160(1): 1-10.
18. Seeliger J, Weise K, Opitz N, Winter R (2012) The effect of Aβ on IAPP aggregation in the presence of an isolated β-cell membrane. J Mol Biol 421(2-3): 348-363.
19. Cheng HT, Megha, London E (2009) Preparation and properties of asymmetric vesicles that mimic cell membranes: Effect upon lipid raft formation and transmembrane helix orientation. J Biol Chem 284(10): 6079-6092.
20. Trikha S, Jeremic AM (2011) Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasmamembrane cholesterol. J Biol Chem286(41): 36086-36097.
21. Mirzabekov TA, Lin MC, Kagan BL (1996) Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem 271(4): 1988-1992.
22. Anguiano M, Nowak RJ, Lansbury PT, Jr. (2002) Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry 41(38): 11338-11343.
23. Last NB, Rhoades E, Miranker AD (2011) Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity. Proc Natl Acad Sci USA 108(23): 9460-9465.
24. Green JD, et al. (2004) Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. J Mol Biol 342(3): 877-887.
25. Sparr E, et al. (2004) Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett 577(1-2): 117-120.
26. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC (1999) The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48(3): 491-498.
27. Porat Y, Kolusheva S, Jelinek R, Gazit E (2003) The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry 42(37): 10971-10977.
28. Weise K, Radovan D, Gohlke A, Opitz N, Winter R (2010) Interaction of hIAPP with model raft membranes and pancreatic beta-cells: Cytotoxicity of hIAPP oligomers. ChemBioChem 11(9): 1280-1290.
29. Brender JR, et al. (2011) Biphasic effects of insulin on islet amyloid polypeptide membrane disruption. Biophys J 100(3): 685-692.
30. Engel MFM, et al. (2008) Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc Natl Acad Sci USA 105(16): 6033-6038.
31. Jayasinghe SA, Langen R (2005) Lipid membranes modulate the structure of islet amyloid polypeptide. Biochemistry 44(36): 12113-12119.
32. Ratner RE, et al. (2004) Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: A 1-year, randomized controlled trial. Diabet Med 21(11): 1204-1212.
33. Meng FL, Raleigh DP, Abedini A (2010) Combination of kinetically selected inhibitors in trans leads to highly effective inhibition of amyloid formation. J Am Chem Soc 132(41): 14340-14342.
34. Yan LM, Tatarek-Nossol M, Velkova A, Kazantzis A, Kapurniotu A (2006) Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis. Proc Natl Acad Sci USA 103(7): 2046-2051.
35. Marek P, et al. (2007) Aromatic interactions are not required for amyloid fibril formation by islet amyloid polypeptide but do influence the rate of fibril formation and fibril morphology. Biochemistry 46(11): 3255-3261.
36. Cao P, et al. (2012) Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20. J Mol Biol 421(2-3): 282-295.
37. Chen RF, Knutson JR (1988) Mechanism of fluorescence concentration quenching of carboxyfluorescein in liposomes: Energy transfer to nonfluorescent dimers. Anal Biochem 172(1): 61-77.
38. Lee TY, et al. (2012) A Co(III) complex cleaving soluble oligomers of h-IAPP in the presence of polymeric aggregates of h-IAPP. Bioorg Med Chem Lett 22(17): 5689-5693.
39. Radovan D, Opitz N, Winter R (2009) Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol. FEBS Lett 583(9): 1439-1445.
40. Jha S, Sellin D, Seidel R, Winter R (2009) Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes. J Mol Biol 389(5): 907-920.
41. Díaz RS, Monreal J, Regueiro P, Lucas M (1992) Preparation of a protein-free total brain white matter lipid fraction: Characterization of liposomes. J Neurosci Res 31(1): 136-145.
42. Demuro A, et al. (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280(17): 17294-17300.
43. Khemtémourian L, Killian JA, Höppener JWM, Engel MFM (2008) Recent insights in islet amyloid polypeptide-induced membrane disruption and its role in beta-cell death in type 2 diabetes mellitus. Exp Diabetes Res 2008:421287.
44. Nath A, Rhoades E (2013) A flash in the pan: Dissecting dynamic amyloid intermediates using fluorescence. FEBS Lett 587(8): 1096-1105.
45. Nanga RP, Brender JR, Xu J, Veglia G, Ramamoorthy A (2008) Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. Biochemistry 47(48): 12689-12697.
46. Brender JR, et al. (2008) Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetesrelated peptide. J Am Chem Soc 130(20): 6424-6429.
47. Nilsson MR, Driscoll M, Raleigh DP (2002) Low levels of asparagine deamidation can have a dramatic effect on aggregation of amyloidogenic peptides: Implications for the study of amyloid formation. Protein Sci 11(2): 342-349.